Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HIIT Promotes M2 Macrophage Polarization and Sympathetic Nerve Density to Induce Adipose Tissue Browning in T2DM Mice. | Biomolecules | 2024 | 38540669 | PubTator, text mining | PubMed |
| Single nuclei transcriptomics of the in situ human limbal stem cell niche. | Sci Rep | 2024 | 38514716 | PubTator, text mining | PubMed |
| CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. | Sci Signal | 2024 | 38502733 | PubTator, text mining | PubMed |
| Construction and validation of a joint diagnosis model based on random forest and artificial intelligence network for hepatitis B-related hepatocellular carcinoma. | Transl Cancer Res | 2024 | 38482416 | PubTator, text mining | PubMed |
| Cytochrome P450 genes expression in human prostate cancer. | Mol Genet Metab Rep | 2024 | 38469085 | PubTator, text mining | PubMed |
| Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure. | Sci Rep | 2024 | 38461325 | PubTator, text mining | PubMed |
| Analysis of the mucosal chemokines CCL28, CXCL14, and CXCL17 in dry eye disease: An in vitro and clinical investigation. | Exp Eye Res | 2024 | 38453037 | PubTator, text mining | PubMed |
| The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy. | Viruses | 2024 | 38400076 | PubTator, text mining | PubMed |
| Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma. | Gene | 2024 | 38367852 | PubTator, text mining | PubMed |
| CXCL14 as a Key Regulator of Neuronal Development: Insights from Its Receptor and Multi-Omics Analysis. | Int J Mol Sci | 2024 | 38338930 | PubTator, text mining | PubMed |
| Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. | Eur J Pharmacol | 2024 | 38309677 | PubTator, text mining | PubMed |
| Whitening of brown adipose tissue inhibits osteogenic differentiation via secretion of S100A8/A9. | iScience | 2024 | 38303710 | PubTator, text mining | PubMed |
| Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment. | Cell Biosci | 2024 | 38303024 | PubTator, text mining | PubMed |
| Osteosarcoma Cells Secrete CXCL14 That Activates Integrin α11β1 on Fibroblasts to Form a Lung Metastatic Niche. | Cancer Res | 2024 | 38295227 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals Cxcl14+ Fibroblast Accumulation in Regenerating Diabetic Wounds Treated by Hydrogel-Delivering Carbon Monoxide. | ACS Cent Sci | 2024 | 38292600 | PubTator, text mining | PubMed |
| MuSCs and IPCs: roles in skeletal muscle homeostasis, aging and injury. | Cell Mol Life Sci | 2024 | 38289345 | PubTator, text mining | PubMed |
| CXCR4 Expression and Cancer-associated Fibroblasts May Play an Important Role in the Invasion of Low-grade Endometrioid Carcinoma. | Int J Gynecol Pathol | 2024 | 38289161 | PubTator, text mining | PubMed |
| Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy. | Eur J Cancer | 2024 | 38278009 | PubTator, text mining | PubMed |
| Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. | Genes (Basel) | 2024 | 38275602 | PubTator, text mining | PubMed |
| Hyperoxia prevents the dynamic neonatal increases in lung mesenchymal cell diversity. | Sci Rep | 2024 | 38263350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=10